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Abstract: 
Objective: This study hopes to compare the severity and control of asthma among patients presenting with and 
without co-morbid rhinitis. 
Methodology:This retrospective, comparative analysis was conducted upon a total of 377 asthmatic patients, 
presenting at the medical out-patient department with and without co-morbid rhinitis. The data was collected using 
a structured interview based questionnaire (after taking written informed consent) which included in-depth inquiries 
regarding the asthma severity and control for the past 4 week. The data obtained was analyzed using SPSS v. 21. 0. 
Results: Among the 377 subjects, 200 were males while 177 were females. Mean age of the subjects was 36 years. 
172 asthmatic patients in the sample suffered from the co-morbid rhinitis, while the remaining did not have the said 
comorbidity. Asthmatic patients with co-morbid rhinitis experienced more frequent asthmatic attacks. The incidence 
of visits to the emergency room and frequency of hospital admissions too was high among asthmatic patients with 
co-morbid rhinitis.  
Conclusion: The results reveal that, all attempts to draw a comparison of asthma severity and control among 
patients with and without comorbid rhinitis yield clear and unidirectional results, leading to a transparent 
conclusion i.e. the asthma severity and control is considerably poorer in asthmatics with co-morbid rhinitis. 
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INTRODUCTION: 
Rhinitis is a high-prevalence disease around the 
world, affecting nearly ten to forty percent of the 
adults everywhere. [1–3]. Prevalence of rhinitis is on 
the rise and the rise has been accelerating for many 
years now, especially in the western world. Evidence 
based research conducted in the western agree with 
the aforementioned statement in nearly all countries 
and all age groups, differing only in the extent of 
acceleration. Up to 15% for children aged six to 
seven years, up to 40% for children aged thirteen to 
fourteen years and up to 41% for adults aged twenty 
to forty four years [1, 2].  
Evidence based analysis, aiming to reach a 
conclusive prevalence of rhinitis among patients with 
asthma, featuring in reputed search engines and 
scientific indices from 1983 to 2004, the prevalence 
ranged from twenty four to ninety four percent, with 
the lifetime prevalence ranging from fifty to hundred 
percent among adults with asthmatic subjects in the 
western world [8]. The relation is also bi-directional, 
and symptoms of asthma are found in patients 
suffering from rhinitis [9].  
The aforementioned also suggests that the two 
ailments are linked in a way that the symptoms of 
asthma, affect rhinitis and the symptoms of rhinitis 
aggravate the severity of asthma and impairs asthma 
control [10–13]. Furthermore, as logic may predict, 
attempts at treating rhinitis yield positive effects on 
asthma as well, in terms of severity and control 
measured by the number of asthma attacks, number 
of visits to the emergency room and frequency of 
hospital admissions [11, 14-16].  
Fresher literature in the evidence pool also showed 
recently that patients of asthma that did not suffer 
from co-morbid rhinitis held a probability of up to 
five times better control of asthma compared to 
patients with co-morbid rhinitis [10]. Likewise, 
surveys in outpatient departments, similar to ours hint 
that long term rhinitis is the strongest correlate of 
visits to the emergency room and hospital admissions 
brought about by exacerbation of asthma and 
increased frequency of asthmatic episodes. The 
purpose of this retrospective comparative analysis 
was to compare the severity and control of asthma 
among patients presenting with and without co-
morbid rhinitis.  
 
METHODOLOGY: 
This retrospective, comparative analysis was 
conducted upon a total of 377 asthmatic patients, 
presenting at the medical out-patient department with 
and without co-morbid rhinitis. The data was 
collected using a structured interview based 
questionnaire (after taking written informed consent) 
which included in-depth inquiries regarding the 
asthma severity and control for the past 4 week. The 
data obtained was analyzed using SPSS v. 21. 0. 
 
RESULTS: 
Among the 377 subjects, 200 were males while 177 
were females.  
literature lists discoveries of unchallengeable 
statistics regarding the epidemiology and 
pathophysiology that rhinitis and asthma are strongly 
associated [4–6]. The prevalence of the comorbidity 
i.e. rhinitis among asthmatic patients is very high, 
reaching up to a hundred percent among patients with 
allergic asthma[5, 7] . 
A scientific meta-  
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Mean age of the subjects was 36 years. 172 asthmatic patients in the sample suffered from the co-morbid rhinitis, 
while the remaining did not have the said comorbidity.  
 
 
Asthmatic patients with co-morbid rhinitis experienced more frequent asthmatic attacks. The incidence of visits to 
the emergency room and frequency of hospital admissions too was high among asthmatic patients with co-morbid 
rhinitis. 
 
 
 
DISCUSSION: 
This retrospective comparative study mirrors closely, 
the real life statistics owing to the efficient 
methodology. This was, to our knowledge, the first 
comparative study done in this regard in patients of 
asthma. Our study was carried out upon a rich sample 
of patients at a study setting that plays host to 
patients from a diverse sociodemographic 
background.  
 
Research literature has continuously been updated 
with fresh studies that provided statistics of the 
epidemiology and pathophysiology and indicated that 
the two ailments, i.e. asthma and rhinitis frequently 
exist together [16-22]. Evidence pertaining to 
epidemiology demonstrates that an approximate 
twenty to sixty percent of patients suffering from 
rhinitis mirror clinical asthma, and more than eighty 
percent of allergic asthmatic patients shadow 
symptoms of rhinitis [17-19]. According to evidence, 
an approximate 1/3rd of all patients with rhinitis have 
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persistent symptoms of asthma [23, 24]. Deeper, 
more extensive research exploring the matter in 
anatomical and physiological perspectives, have 
given rise to decisive evidence pertaining to the 
bronchi and nose [21-24]. In addition to that, a 
similarity is also present among the triggering agents 
that aggravate asthma. Furthermore, the resultant 
inflammatory responses as a result of the said triggers 
are also the same [22-26]. 
Hence the fact that attempts at treating rhinitis yield 
positive effects on asthma as well, in terms of 
severity and control measured by the number of 
asthma attacks, number of visits to the emergency 
room and frequency of hospital admissions [11, 14-
16].  
 
CONCLUSION: 
The results reveal that, all attempts to draw a 
comparison of severity and control of asthma among 
patients with and without comorbid rhinitis yield 
clear and unidirectional results, leading to a 
transparent conclusion i.e. the severity and control of 
asthma is considerably poorer in asthmatics with co-
morbid rhinitis. 
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